TY - JOUR
T1 - Factors Associated with Head and Neck Cancer Postoperative Radiotherapy Delays
T2 - A Systematic Review and Meta-analysis
AU - Duckett, Kelsey A.
AU - Kassir, Mohamed Faisal
AU - Nguyen, Shaun A.
AU - Brennan, Emily A.
AU - Chera, Bhisham S.
AU - Sterba, Katherine R.
AU - Halbert, Chanita Hughes
AU - Hill, Elizabeth G.
AU - McCay, Jessica
AU - Puram, Sidharth V.
AU - Jackson, Ryan S.
AU - Sandulache, Vlad C.
AU - Kahmke, Russel
AU - Osazuwa-Peters, Nosayaba
AU - Ramadan, Salma
AU - Nussenbaum, Brian
AU - Alberg, Anthony J.
AU - Graboyes, Evan M.
N1 - Publisher Copyright:
© 2024 American Academy of Otolaryngology–Head and Neck Surgery Foundation.
PY - 2024
Y1 - 2024
N2 - Objective: Initiating postoperative radiotherapy (PORT) within 6 weeks of surgery for head and neck squamous cell carcinoma (HNSCC) is included in the National Comprehensive Cancer Network Clincal Practice Guidelines and is a Commission on Cancer quality metric. Factors associated with delays in starting PORT have not been systematically described nor synthesized. Data Sources: PubMed, Scopus, and CINAHL. Review Methods: We included studies describing demographic characteristics, clinical factors, or social determinants of health associated with PORT delay (>6 weeks) in patients with HNSCC treated in the United States after 2003. Meta-analysis of odds ratios (ORs) was performed on nonoverlapping datasets. Results: Of 716 unique abstracts reviewed, 21 studies were included in the systematic review and 15 in the meta-analysis. Study sample size ranged from 19 to 60,776 patients. In the meta-analysis, factors associated with PORT delay included black race (OR, 1.46, 95% confidence interval [CI]: 1.28-1.67), Hispanic ethnicity (OR, 1.37, 95% CI, 1.17-1.60), Medicaid or no health insurance (OR, 2.01, 95% CI, 1.90-2.13), lower income (OR, 1.38, 95% CI, 1.20-1.59), postoperative admission >7 days (OR, 2.92, 95% CI, 2.31-3.67), and 30-day hospital readmission (OR, 1.37, 95% CI, 1.29-1.47). Conclusion: Patients at greatest risk for a delay in initiating guideline-adherent PORT include those who are from minoritized communities, of lower socioeconomic status, and experience postoperative challenges. These findings provide the foundational evidence needed to deliver targeted interventions to enhance equity and quality in HNSCC care delivery.
AB - Objective: Initiating postoperative radiotherapy (PORT) within 6 weeks of surgery for head and neck squamous cell carcinoma (HNSCC) is included in the National Comprehensive Cancer Network Clincal Practice Guidelines and is a Commission on Cancer quality metric. Factors associated with delays in starting PORT have not been systematically described nor synthesized. Data Sources: PubMed, Scopus, and CINAHL. Review Methods: We included studies describing demographic characteristics, clinical factors, or social determinants of health associated with PORT delay (>6 weeks) in patients with HNSCC treated in the United States after 2003. Meta-analysis of odds ratios (ORs) was performed on nonoverlapping datasets. Results: Of 716 unique abstracts reviewed, 21 studies were included in the systematic review and 15 in the meta-analysis. Study sample size ranged from 19 to 60,776 patients. In the meta-analysis, factors associated with PORT delay included black race (OR, 1.46, 95% confidence interval [CI]: 1.28-1.67), Hispanic ethnicity (OR, 1.37, 95% CI, 1.17-1.60), Medicaid or no health insurance (OR, 2.01, 95% CI, 1.90-2.13), lower income (OR, 1.38, 95% CI, 1.20-1.59), postoperative admission >7 days (OR, 2.92, 95% CI, 2.31-3.67), and 30-day hospital readmission (OR, 1.37, 95% CI, 1.29-1.47). Conclusion: Patients at greatest risk for a delay in initiating guideline-adherent PORT include those who are from minoritized communities, of lower socioeconomic status, and experience postoperative challenges. These findings provide the foundational evidence needed to deliver targeted interventions to enhance equity and quality in HNSCC care delivery.
KW - Commission on Cancer
KW - National Comprehensive Cancer Network
KW - adjuvant therapy
KW - head and neck cancer
KW - health equity
KW - quality
KW - radiotherapy
KW - social determinants of health
UR - http://www.scopus.com/inward/record.url?scp=85195388877&partnerID=8YFLogxK
U2 - 10.1002/ohn.835
DO - 10.1002/ohn.835
M3 - Review article
C2 - 38842034
AN - SCOPUS:85195388877
SN - 0194-5998
JO - Otolaryngology - Head and Neck Surgery (United States)
JF - Otolaryngology - Head and Neck Surgery (United States)
ER -